Is Mounjaro safe for everyone — and what does that mean in practice?

Step 1: establishing who Mounjaro is licensed for

The licensed criteria for tirzepatide in the UK cover adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition. That list includes type 2 diabetes, hypertension, high cholesterol and obstructive sleep apnoea, among others. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Those headline numbers are the starting point, not the finish line, a prescriber then looks at the full picture. The NHS tirzepatide patient information page summarises who should and should not take it, and it is worth reading alongside any consultation.

Age matters too. Mounjaro is not licensed for use in people under 18, and the trial programme that generated the safety evidence was conducted in adults. If you are exploring options for a teenager, our page on Mounjaro safety for teens covers what the evidence does and does not show.

Pregnancy and breastfeeding are absolute contraindications: the medicine is not recommended during either, nor for anyone actively trying to conceive. Women on oral contraceptives starting Mounjaro should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because gut-motility changes may reduce pill absorption. That is a practical step worth knowing before the first injection, not an afterthought.

Step 2: the conditions and medicines that require extra care

Several situations mean Mounjaro either cannot be prescribed or needs careful prescriber judgement. A personal or family history of medullary thyroid carcinoma, or of a condition called MEN2, rules it out entirely. Active or previous pancreatitis requires detailed discussion, the MHRA issued a Drug Safety Update in January 2026 flagging acute pancreatitis as an infrequent but serious risk across GLP-1 medicines, and prescribers factor that into every assessment.

Certain gastrointestinal conditions, significant kidney or liver disease, and a history of eating disorders all call for careful weighing of benefit against risk. Mounjaro can slow gastric emptying, which affects how other medicines are absorbed, if you take levothyroxine, oral contraceptives, or medicines with a narrow therapeutic window, your prescriber needs to know. Our guide to Mounjaro safety in use goes into more detail on interactions.

The consultation at nume is a structured clinical review, not a checkbox exercise. A GPhC-registered Independent Prescriber reads your answers personally the same day. If anything in your health history needs clarification, they will ask, that is how the process is supposed to work.

Step 3: what side effects actually look like day to day

The common side effects of Mounjaro are predominantly gastrointestinal: nausea, constipation, diarrhoea, reflux, burping and fatigue are the ones people notice most. They tend to be most prominent after starting treatment or after a dose step-up, and for many patients they ease within one to two weeks. Keeping the pen in the fridge door and dosing on the same day each week helps build a routine, which in turn makes it easier to notice if something feels different from the usual adjustment period.

Not everyone experiences these effects to the same degree. The question of how common they actually are, and what influences who gets them, is covered in our separate page on whether everyone gets side effects from Mounjaro. The short answer: no, but knowing what to expect makes a significant difference to how patients manage the early weeks. Our Mounjaro sick-day rules page is useful reading if nausea or vomiting becomes disruptive.

When to get medical help immediately

Most side effects are manageable without urgent intervention. A few are not. Get medical help quickly (call 111 or go to A&E if necessary) for any of the following: severe, persistent stomach pain, especially if it spreads to your back, with or without vomiting (this can indicate pancreatitis); symptoms of gallbladder problems, including sharp pain in the upper right abdomen; signs of significant dehydration after prolonged vomiting or diarrhoea; any symptoms suggesting a serious allergic reaction, including swelling of the face, lips or throat; or a sudden change in mood, low mood or thoughts of self-harm.

If you experience anything that concerns you and it falls outside these categories, contact your prescriber. At nume that means our aftercare team, available seven days a week. Always report suspected side effects via the MHRA Yellow Card scheme, especially important given Mounjaro's Black Triangle status, which means the regulator is actively collecting post-market safety data. You can also find detailed safety information in the Mounjaro SmPC on the eMC.

If you have questions about how Mounjaro fits your specific health history, our prescribers discuss suitability and side effects as a core part of the consultation. Speak to our prescribers through a free consultation, same-day clinical review, no waiting list.